Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300204 Staidson (Beijing) Biopharmaceuticals Co Ltd SZSE:300204
46 GF Score
Price ¥20.94
GF Value ¥4.34
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Staidson (Beijing) Biopharmaceuticals Co FFO?

FFO (Funds from operations) only applies to REITs.

SZSE:300204
46GF Score
Staidson (Beijing) Biopharmaceuticals Co Ltd SZSE:300204
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Overvalued in 2026?

Based on GuruFocus' analysis, Staidson (Beijing) Biopharmaceuticals Co stock appears to be overvalued. The current stock price of ¥20.94 is trading 382.5% above its estimated GF Value™ of ¥4.34. GuruFocus considers Staidson (Beijing) Biopharmaceuticals Co to be Significantly Overvalued.

Key valuation signals for SZSE:300204:

  • FFO:
  • GF Value™: ¥4.34 vs. price of ¥20.94 (382.5% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the SZSE:300204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staidson (Beijing) Biopharmaceuticals Co Business Description

Address Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
46GF Score

Get the complete analysis for SZSE:300204

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.94
Price
¥4.34
GF Value